BRSV stands for Bovine Respiratory Syncytial Virus, one of the most common viral causes of respiratory illness in cattle. It is a single-stranded RNA virus that infects the lower airways and lungs, often triggering severe pneumonia in calves and occasionally in adult cows. BRSV rarely acts alone. It frequently opens the door to secondary bacterial infections, making it a key player in the broader condition known as Bovine Respiratory Disease (BRD) complex, the leading cause of illness and death in young cattle worldwide.
How BRSV Spreads
BRSV passes between animals through direct contact and respiratory droplets, much like a cold spreads between people. Coughing, nasal discharge, and shared air space in barns or feedlots all contribute. Several factors influence how quickly an outbreak moves through a herd: population density, the immune status of the animals, environmental conditions, and overall management practices.
Outbreaks tend to peak in summer and winter, though the virus can circulate year-round. Intensive and large-scale operations generally see higher infection rates and heavier viral loads compared to smaller pastoral operations, likely because animals are housed more closely together and stress levels run higher. Once BRSV enters a herd, it can spread rapidly, especially among young, immunologically naive calves.
Signs and Symptoms
The incubation period for BRSV is short, typically 2 to 5 days from exposure to the first signs of illness. Early symptoms often look like a general respiratory infection:
- Fever ranging from 104°F to 108°F (40–42°C)
- Listlessness and decreased feed intake
- Increased breathing rate
- Coughing
- Nasal and eye discharge
In mild outbreaks, animals may recover without progressing further. But in moderate to severe cases, labored breathing becomes pronounced, sometimes with open-mouthed breathing as lung function deteriorates. A small percentage of cases develop fatal interstitial pneumonia, where the tissue between the air sacs in the lungs becomes severely inflamed and thickened.
One of the more distinctive signs of severe BRSV is subcutaneous emphysema, a crackling or puffy swelling felt under the skin, usually along the back near the withers. This happens when damaged lung tissue ruptures, allowing trapped air to track along tissue layers beneath the skin. It typically appears several days after respiratory distress begins. That said, subcutaneous emphysema is not unique to BRSV. Any severe pneumonia can cause it, so its presence alone is not enough to confirm the diagnosis.
BRSV’s Role in Bovine Respiratory Disease
BRSV is rarely the end of the story. The virus damages the lining of the airways and suppresses local immune defenses, creating ideal conditions for bacteria that normally live harmlessly in the upper respiratory tract to invade the lungs. Secondary bacterial pneumonia is a frequent complication, and it is often the bacterial infection, not the virus itself, that causes the most serious damage or death.
In studies of calves diagnosed with BRD, over half tested positive for BRSV, making it one of the most commonly detected viruses in the complex. The combination of viral damage and bacterial invasion is what makes BRD so costly to the cattle industry. Sick calves that survive often face setbacks in growth, delayed breeding timelines, and long-term respiratory compromise. The cost of raising a heifer through these setbacks commonly ranges from $1,700 to $2,400 when factoring in treatment, lost growth, and reproductive delays.
How BRSV Is Diagnosed
Diagnosing BRSV based on symptoms alone is difficult because the early signs overlap with many other respiratory infections. Laboratory testing on nasal swabs is the standard approach. Two methods work well for field diagnosis: PCR testing, which detects the virus’s genetic material, and antigen-capture ELISA, which identifies specific viral proteins.
Both PCR and ELISA can detect the virus at low levels and do not require the careful, rapid sample handling that older virus isolation techniques demand. PCR, in particular, can pick up virus shedding for a longer window after infection than traditional culture methods, likely because it detects viral material even after the animal’s immune system has begun neutralizing live virus. For producers working with a veterinarian, nasal swabs from acutely affected animals (those showing symptoms for only a day or two) yield the most reliable results.
Treatment and Supportive Care
There is no antiviral drug that kills BRSV directly. Treatment focuses on managing symptoms, supporting the animal through the viral phase, and preventing or treating secondary bacterial infections before they become fatal. Anti-inflammatory medications help reduce fever, ease breathing, and improve comfort. When bacterial pneumonia is suspected or confirmed, antibiotics are selected based on the bacteria most likely involved, ideally guided by culture results from the specific herd.
Early detection matters enormously. Calves identified and treated at the first signs of illness have significantly better outcomes than those caught after the disease has progressed. Many operations use clinical scoring systems that combine observations of temperature, nasal discharge, cough, ear position, and overall attitude. A composite score above a set threshold triggers treatment. The goal is to catch cases before the lungs sustain irreversible damage.
Vaccination Strategies
Vaccination against BRSV is widely practiced but comes with a challenge: the virus’s immune-evading properties make it harder to build lasting protection compared to some other cattle vaccines. The immune response itself appears to contribute to lung damage during infection, which complicates vaccine design.
Two main vaccine types are available. Modified-live vaccines contain a weakened form of the virus that replicates briefly to stimulate immunity. Inactivated vaccines contain killed virus combined with an immune-boosting ingredient called an adjuvant. Both are typically bundled into combination vaccines that also cover other common respiratory viruses.
Timing and sequence matter. A well-studied approach involves giving calves an intranasal (nose-delivered) modified-live vaccine within 24 hours of birth, then following up with a booster injection at around 2 months of age. Research comparing booster types found that calves given an inactivated booster after intranasal priming mounted a stronger immune response when later exposed to BRSV than calves given a modified-live booster. The inactivated-booster group had significantly higher antibody levels by 7 days after exposure and maintained better blood oxygen levels, averaging 87 mmHg compared to 70 mmHg in the modified-live group. That oxygen difference reflects meaningfully better lung function during active infection.
Vaccination does not guarantee complete protection, but it reduces the severity of disease and lowers the risk of outbreaks spiraling into costly herd-wide events. Working with a veterinarian to tailor the vaccine program to a herd’s specific risk factors, including timing around weaning and transport, gives the best results.
Reducing Outbreak Risk
Beyond vaccination, management practices play a major role in controlling BRSV. Minimizing stress during high-risk periods like weaning, transport, and commingling with new animals helps keep immune defenses intact. Adequate ventilation in barns reduces the concentration of airborne virus. Keeping calves in smaller, stable groups rather than large mixed populations limits how far and fast the virus can spread.
New animals entering a herd represent one of the biggest risk points. Quarantine periods allow time to observe for respiratory signs before newcomers mix with the resident population. On operations where BRSV has been a recurring problem, reviewing the entire management chain, from colostrum quality in newborns to housing density in feedlots, often reveals specific pressure points where targeted changes can break the cycle.